| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | THORATEC LABS CORP | 5,000 | 316,000 | 0.06% | ||
| 2 | SECOND SIGHT MED PRODS INC | 203,438 | 1,206,000 | 0.25% | ||
| 3 | ZIOPHARM ONCOLOGY INC | 134,208 | 1,209,000 | 0.25% | ||
| 4 | METABOLIX INC RESTRICTED | 957,720 | 1,322,000 | 0.27% | ||
| 5 | BIOGEN INC | 7,723 | 2,248,000 | 0.46% | ||
| 6 | REGULUS THERAPEUTICS INC COM | 374,532 | 2,449,000 | 0.50% | ||
| 7 | CONTRAFECT CORP COM | 1,182,032 | 5,260,000 | 1.08% | ||
| 8 | TRANSITION THERAPEUTICS INC | 3,966,022 | 7,099,000 | 1.45% | ||
| 9 | BIOLASE INC | 10,474,725 | 9,427,000 | 1.93% | ||
| 10 | WEBMD HEALTH CORP | 238,103 | 9,486,000 | 1.94% | ||
| 11 | AMARIN CORP PLC | 6,076,878 | 11,728,000 | 2.40% | ||
| 12 | PACIFIC BIOSCIENCES CALIF IN | 3,236,161 | 11,844,000 | 2.42% | ||
| 13 | ACCURAY INCORPORATED COM | 2,884,305 | 14,407,000 | 2.95% | ||
| 14 | AGENUS INC | 3,250,609 | 14,953,000 | 3.06% | ||
| 15 | HANSEN MEDICAL INC | 4,491,816 | 16,889,000 | 3.45% | ||
| 16 | VERMILLION INC | 8,624,225 | 17,248,000 | 3.53% | ||
| 17 | TESARO INCORPORATED | 494,250 | 19,819,000 | 4.05% | ||
| 18 | ACORDA THERAPEUTICS INC | 815,838 | 21,628,000 | 4.42% | ||
| 19 | INTREXON CORPORATION | 804,877 | 25,595,000 | 5.24% | ||
| 20 | MAZOR ROBOTICS LTD | 2,492,911 | 27,497,000 | 5.62% | ||
| 21 | OPKO HEALTH INC | 4,000,000 | 33,640,000 | 6.88% | ||
| 22 | CHIMERIX INC | 986,421 | 37,681,000 | 7.71% | ||
| 23 | QUIDEL CORP COM | 2,816,284 | 53,171,000 | 10.88% | ||
| 24 | NXSTAGE MED INC COM | 3,485,078 | 54,960,000 | 11.24% | ||
| 25 | ACCELERATE DIAGNOSTICS INC | 5,425,893 | 87,791,000 | 17.96% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001085146-15-002438, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
